(Q87177751)
Statements
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy (English)
Johanna Bendell
Guy Jerusalem
Shaun Su
Qinhua Ru
Stefan De Buck
David Mills
Sophie Ruquet
Ana Bosch
Joseph T Beck
Emmanuelle Di Tomaso
David W Sternberg
Cristian Massacesi
Samit Hirawat
Luc Dirix